CPSA USA 2020
Bridging Better Data to Improved Clinical Outcomes:
How to Translate Innovation into Better Decision Making
Chairs: Mark Cancilla, Merck and Daniel Spellman, Merck
2019 Innovator Award Recipients
Ryan Ragland | Biomeme Inc.
Daniel DeBord | MOBILion Systems, Inc
Mark Hail | Novatia
Abstracts are being accepted for the 7th Annual CPSA 2020 Innovator Awards!
The CPSA Innovator Award provides formal recognition for innovative technologies, products and services presented at the annual meeting.
The Innovator Awards Session is open to all sponsor and exhibiting companies at CPSA USA.
Applicants can apply for consideration either an abstract for poster session or a standalone abstract without participating in the poster session
Applications will be formally reviewed by the Innovator Award Committee.
Selected participants will be assigned to present in the Innovator Award Session on Thursday, October 31st.
There is no limit to the number of submissions per exhibitor, however, each application must describe a unique technology, product and/or service as reviewed by the Innovator Award Committee. Preference will be given to submissions best aligned with the 202 theme of Bridging Better Data to Improved Clinical Outcomes:
How to Translate Innovation into Better Decision Making.
Deadline: All abstracts must be received by September 21, 2020.
Using the form below, submit your abstract for consideration in the Innovator Award Session at CPSA USA.
If you also have a poster presentation for this abstract and would like to participate in the poster session, please indicate that in the registration. There is no need to also submit your abstract for the poster session.
Innovator Session Abstract Submission